G-H-3 International Inc. (OTCPK: GHTI)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
G-H-3 International Inc. (OTCPK: GHTI) operates in the Pharmaceuticals industry within the Health Care sector.
trading between 0.00 and 0.00.
GHTI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 2.94
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 0
- Next earnings
- —
About G-H-3 International Inc.
G-H-3 International Inc. specializes in developing solutions designed to counteract the processes that contribute to bodily aging and decline. Their flagship offering, G-H-3-Plus, is an all-encompassing program formulated to provide anti-aging benefits, aid in the management of chronic illnesses, and enhance overall vitality and well-being. This G-H-3-Plus regimen integrates a variety of therapeutic components, including intravenous treatments, intramuscular injections, prescribed medications, nutritional supplements, and skincare products. Based in Las Vegas, Nevada, the company was previously known as The Chelsea Collection, Inc. before its name change to G-H-3 International Inc.
- ISIN
- US36172E1055
- Listed since
- Jun 5, 2023
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.02 | -0.75% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $272.63 | +0.88% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.68 | -1.23% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.04 | -0.12% |
Figures last refreshed Aug 18, 2026.